Miami、FLにおけるCOPDの臨床試験
Miamiとその周辺地域（約30マイル以内）の拠点で、COPDに関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
被験者募集中第3相
- Elite Clinical Research - Miami- Site Number : 8400167, Miami
- DL Research Solutions- Site Number : 8400140, Miami
- Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
- 他3件
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
被験者募集中第2相
- Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
被験者募集中第2相
- Millennium Medical Research - Miami, Miami
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
被験者募集中第3相
- GSK Investigational Site, Miami
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
被験者募集中第4相
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
被験者募集中第3相
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
- MCR Research- Site Number : 8400004, Miami
- Nuren Medical & Research Center- Site Number : 8400030, Miami
- 他1件
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
被験者募集中第2相
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
- 他2件
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
被験者募集中第3相
- Research Site, Miami
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
被験者募集中第3相
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
被験者募集中第2/3相
- Reed Medical Research, Miami
Rademikibart IV for Acute Asthma and COPD Exacerbation
被験者募集中第2相
- Columbus Clinical Services, LLC, Miami
- Pharmax Research of South Florida, Inc., Miami
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
被験者募集中第3相
- Research Site, Miami
- Research Site, Miami
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
被験者募集中第3相
- GC2501 Study Site 105, Miami
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
被験者募集中第3相
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
被験者募集中
- University of Miami, Miami
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
被験者募集中第3相
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- 他4件
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
被験者募集中第3相
- GSK Investigational Site, Miami
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
被験者募集中
- Reliable Research, Inc., Miami
- NewGen Health Group, Miami
他の都市におけるCOPDの試験
- Philadelphia, PA23件の研究
- Birmingham, AL17件の研究
- Boston, MA17件の研究
- Orlando, FL15件の研究
- Houston, TX15件の研究
- Baltimore, MD14件の研究
- Chicago, IL14件の研究
- Pittsburgh, PA12件の研究
- Dallas, TX12件の研究
- New York City, NY11件の研究
- Ann Arbor, MI10件の研究
- Detroit, MI9件の研究
Miamiにおける他の研究
- 乳がん42件の研究
- がん（全種類）36件の研究
- 非小細胞肺癌31件の研究
- 前立腺がん27件の研究
- 肥満症27件の研究
- 急性骨髄性白血病24件の研究
- 卵巣がん23件の研究
- 過体重23件の研究
- 転移性癌23件の研究
- 潰瘍性大腸炎22件の研究
- 多発性骨髄腫21件の研究
- アルツハイマー病20件の研究
ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。